Device Trial Radar · NCT03456583
Brevera™ Breast Biopsy System Data Collection Study
Last checked: Nov 19, 2026Latest source record: Oct 8, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
500
Actual
Start
Nov 20, 2017
Primary completion
Nov 20, 2018
Study completion Nov 20, 2018
Sponsor
- Lead sponsor
- Hologic, Inc.Public (HOLX)
- Sponsor type
- Industry
- First posted
- Mar 7, 2018
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Brevera Breast Biopsy System integrates tissue acquisition, real time imaging, and post biopsy handling all during the same procedure. This post-market clinical trial will be performed to obtain clinical/operational data and feedback on the Brevera Breast Biopsy System.
Conditions
- Breast Cancer Female
Interventions
Brevera Breast Biopsy SystemDevice
The Brevera Breast Biopsy System with CorLumina imaging technology is a vacuum-assisted biopsy device, which is used to remove breast tissue in a minimally invasive manner using stereotactic or tomosynthesis imaging. A breast biopsy is a test that removes tissue or sometimes fluid from the suspicious area. The removed cells are examined under a microscope and further tested to check for the presence of breast cancer. A biopsy is a diagnostic procedure that can definitely determine if the suspicious area is cancerous.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Procedural TimeTime frame: Through study completion, enrollment expected to take up to 6-10 months at each site - Data collected from day of Breast Biopsy Procedure Only
Locations
6 sites in 6 countries. Site status is shown where the registry gives one.
Institut régional du Cancer de Montpellier
Montpellier, France
Brustdiagnostik Munchen
Tübingen, Germany
Radiologia Senologica
Milan, Italy
3 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.